316 related articles for article (PubMed ID: 27190098)
1. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.
Hifinger M; Hiligsmann M; Ramiro S; Watson V; Severens JL; Fautrel B; Uhlig T; van Vollenhoven R; Jacques P; Detert J; Canas da Silva J; Scirè CA; Berghea F; Carmona L; Péntek M; Keat A; Boonen A
Ann Rheum Dis; 2017 Jan; 76(1):126-132. PubMed ID: 27190098
[TBL] [Abstract][Full Text] [Related]
2. Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists.
Hifinger M; Hiligsmann M; Ramiro S; Severens JL; Fautrel B; Watson V; Boonen A
Rheumatology (Oxford); 2017 Jan; 56(1):68-76. PubMed ID: 28028156
[TBL] [Abstract][Full Text] [Related]
3. Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists.
Hifinger M; Hiligsmann M; Ramiro S; Watson V; Berghea F; Péntek M; Keat A; Severens JL; Fautrel B; Boonen A
RMD Open; 2017; 3(2):e000453. PubMed ID: 28912960
[TBL] [Abstract][Full Text] [Related]
4. Preferences for treatments to prevent rheumatoid arthritis in Canada and the influence of shared decision-making.
Harrison M; Bansback N; Aguiar M; Koehn C; Shojania K; Finckh A; Hudson M
Clin Rheumatol; 2020 Oct; 39(10):2931-2941. PubMed ID: 32248434
[TBL] [Abstract][Full Text] [Related]
5. Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment.
Augustovski F; Beratarrechea A; Irazola V; Rubinstein F; Tesolin P; Gonzalez J; Lencina V; Scolnik M; Waimann C; Navarta D; Citera G; Soriano ER
Value Health; 2013; 16(2):385-93. PubMed ID: 23538191
[TBL] [Abstract][Full Text] [Related]
6. Doctors' preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment.
Kuijper TM; Folmer R; Stolk EA; Hazes JMW; Luime JJ
Arthritis Res Ther; 2017 Apr; 19(1):78. PubMed ID: 28446212
[TBL] [Abstract][Full Text] [Related]
7. Impact of falling reimbursement rates on physician preferences regarding drug therapy for osteoarthritis using a discrete choice experiment.
Berchi C; Degieux P; Halhol H; Danel B; Bennani M; Philippe C
Int J Pharm Pract; 2016 Apr; 24(2):114-22. PubMed ID: 26383231
[TBL] [Abstract][Full Text] [Related]
8. What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis.
Díaz-Torné C; Urruticoechea-Arana A; Ivorra-Cortés J; Díaz S; Dilla T; Sacristán JA; Inciarte-Mundo J; Comellas M; Prades M; Lizán L
Adv Ther; 2020 Apr; 37(4):1479-1495. PubMed ID: 32088860
[TBL] [Abstract][Full Text] [Related]
9. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
Harrison M; Marra C; Shojania K; Bansback N
Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
[TBL] [Abstract][Full Text] [Related]
10. Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis.
Fraenkel L; Nowell WB; Michel G; Wiedmeyer C
Ann Rheum Dis; 2018 May; 77(5):678-683. PubMed ID: 29247126
[TBL] [Abstract][Full Text] [Related]
11. A discrete-choice experiment to elicit preferences of patients with epilepsy for self-management programs.
Atkinson-Clark E; Charokopou M; Van Osselaer N; Hiligsmann M
Epilepsy Behav; 2018 Feb; 79():58-67. PubMed ID: 29248866
[TBL] [Abstract][Full Text] [Related]
12. What do Australian patients with inflammatory arthritis value in treatment? A discrete choice experiment.
Ho KA; Acar M; Puig A; Hutas G; Fifer S
Clin Rheumatol; 2020 Apr; 39(4):1077-1089. PubMed ID: 31858340
[TBL] [Abstract][Full Text] [Related]
13. Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania.
Simons G; Veldwijk J; DiSantostefano RL; Englbrecht M; Radawski C; Bywall KS; Valor Méndez L; Hauber B; Raza K; Falahee M
Rheumatology (Oxford); 2023 Feb; 62(2):596-605. PubMed ID: 36068022
[TBL] [Abstract][Full Text] [Related]
14. Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.
Hiligsmann M; Dellaert BG; Dirksen CD; Watson V; Bours S; Goemaere S; Reginster JY; Roux C; McGowan B; Silke C; Whelan B; Diez-Perez A; Torres E; Papadakis G; Rizzoli R; Cooper C; Pearson G; Boonen A
Rheumatology (Oxford); 2017 Jul; 56(7):1167-1176. PubMed ID: 28398547
[TBL] [Abstract][Full Text] [Related]
15. Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment.
Hazlewood GS; Bombardier C; Tomlinson G; Thorne C; Bykerk VP; Thompson A; Tin D; Marshall DA
Rheumatology (Oxford); 2016 Nov; 55(11):1959-1968. PubMed ID: 27477807
[TBL] [Abstract][Full Text] [Related]
16. Rheumatologists' insight into medication adherence in patients with rheumatoid arthritis: A qualitative study.
Heidari P; Cross W; Weller C; Team V; Nazarinia M; Crawford K
Int J Rheum Dis; 2019 Sep; 22(9):1695-1705. PubMed ID: 31322831
[TBL] [Abstract][Full Text] [Related]
17. Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients.
Bywall KS; Kihlbom U; Hansson M; Falahee M; Raza K; Baecklund E; Veldwijk J
Arthritis Res Ther; 2020 Dec; 22(1):288. PubMed ID: 33341117
[TBL] [Abstract][Full Text] [Related]
18. The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
Clark W; Jobanputra P; Barton P; Burls A
Health Technol Assess; 2004 May; 8(18):iii-iv, ix-x, 1-105. PubMed ID: 15130461
[TBL] [Abstract][Full Text] [Related]
19. Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study.
Hazlewood GS; Loyola-Sanchez A; Bykerk V; Hull PM; Marshall D; Pham T; Barber CEH; Barnabe C; Sirois A; Pope J; Schieir O; Richards D; Proulx L; Bartlett SJ
Rheumatology (Oxford); 2022 Feb; 61(2):606-616. PubMed ID: 33878168
[TBL] [Abstract][Full Text] [Related]
20. A Bayesian model that jointly considers comparative effectiveness research and patients' preferences may help inform GRADE recommendations: an application to rheumatoid arthritis treatment recommendations.
Hazlewood GS; Bombardier C; Tomlinson G; Marshall D
J Clin Epidemiol; 2018 Jan; 93():56-65. PubMed ID: 29051108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
